Molecular scanning of the gene for programmed cell death-1 (PDCD-1) as a candidate for type 1 diabetes susceptibility

Yoshihisa Hiromine1, Hiroshi Ikegami, Tomomi Fujisawa

  • 1Department of Endocrinology, Metabolism and Diabetes, Kinki University School of Medicine, 377-2 Ohno-higashi, Osaka-Sayama, Osaka 589-8511, Japan.

Insights

Researchers investigated the PDCD1 gene

Area of Science:

  • Immunology
  • Genetics

Background:

  • Autoimmune type 1 diabetes involves multiple genes.
  • Programmed cell death-1 (PDCD-1) regulates peripheral tolerance and may influence type 1 diabetes development.
  • The human PDCD1 gene is a candidate for type 1 diabetes susceptibility.

Purpose of the Study:

  • To sequence the human PDCD1 gene in Japanese subjects.
  • To identify sequence variants within the PDCD1 gene.
  • To investigate the association of PDCD1 polymorphisms with type 1 diabetes susceptibility.

Main Methods:

  • Sequencing of all 5 exons and exon-intron junctions of the PDCD1 gene.
  • Analysis of sequence variants in Japanese individuals.
  • Preliminary association study with type 1 diabetes.

Main Results:

  • Ten sequence variants were identified in the PDCD1 gene.
  • Preliminary data indicated no association between these PDCD1 polymorphisms and type 1 diabetes.
  • The identified variants provide a resource for future research.

Conclusions:

  • The studied PDCD1 sequence variants do not appear to be associated with type 1 diabetes in the Japanese population.
  • Further research is needed to fully elucidate the role of PDCD1 in type 1 diabetes pathogenesis.
  • The identified variants are valuable for future genetic studies of type 1 diabetes.

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...